Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: A randomised controlled 6-week trial
Helgo Magnussen, Henrik Watz, Anne Kirsten, Millie Wang, Heather Wray, Viktoria Samuelsson, John Mo, Richard KayVolume:
24
Year:
2011
Language:
english
DOI:
10.1016/j.pupt.2011.05.003
File:
PDF, 292 KB
english, 2011